Ensign Peak Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.45M | Hold |
|
|||||
|
2025
Q1 | $8.47M | Buy |
|
|||||
|
2024
Q4 | $3.54M | Sell |
|
|||||
|
2024
Q3 | $6.97M | Sell |
|
|||||
|
2024
Q2 | $10.7M | Buy |
|
|||||
|
2024
Q1 | $12.3M | Hold |
|
|||||
|
2023
Q4 | $11.1M | Hold |
|
|||||
|
2023
Q3 | $7.48M | Buy |
|
|||||
|
2023
Q2 | $8.13M | Buy |
|
|||||
|
2023
Q1 | $4.97M | Hold |
|
|||||
|
2022
Q4 | $5.99M | Buy |
|
|||||
|
2022
Q3 | $5.08M | Buy |
|
|||||
|
2022
Q2 | $2.43M | Buy |
|
|||||
|
2022
Q1 | $1.05M | Hold |
|
|||||
|
2021
Q4 | $1.33M | Sell |
|
|||||
|
2021
Q3 | $3.8M | Buy |
|
|||||
|
2021
Q2 | $963K | Hold |
|
|||||
|
2021
Q1 | $1.25M | Buy |
|
|||||
|
2020
Q4 | $911K | Hold |
|
|||||
|
2020
Q3 | $604K | Buy |
|
|||||
|
2020
Q2 | $266K | Buy |
|
|||||
|
2020
Q1 | $127K | Sell |
|
|||||
|
2019
Q4 | $204K | Buy |
|